FX006
HSC-MS-18-0672
Phase 2 small_molecule completed
Quick answer
FX006 for Trochanteric Bursitis is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Trochanteric Bursitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed